Skip to main content

Table 1 Clinical characteristics of HCC patients from TCGA and ICGC database

From: Disulfidptosis-related signature predicts prognosis and characterizes the immune microenvironment in hepatocellular carcinoma

 

TCGA

ICGC

Overall

Age (years)

 Mean (SD)

59.6 (13.4)

67.0 (10.2)

62.3 (12.8)

 Median

61.0

69.0

64.0

Gender

 Female

119 (32.6%)

50 (24.6%)

169 (29.8%)

 Male

246 (67.4%)

153 (75.4%)

399 (70.2%)

TNM stage

 I

170 (46.6%)

33 (16.3%)

203 (35.7%)

 II

84 (23"0%)

96 (47.3%)

180 (31"7%)

 III

83 (22.7%)

59 (29.1%)

142 (25.0%)

 IV

4 (1.1%)

15 (7.4%)

19(3.3%)

 Unknow

24 (6.6%)

0 (0%)

24 (4.2%)

Survival status

 Alive

234(64.1%)

168 (82.8%)

402 (70.8%)

 Dead

130 (35.6%)

35 (17.2%)

165 (29.0%)

 Not reported

1 (0.3%)

0 (0%)

1 (0.2%)

OS time (days)

 Mean (SD)

813 (726)

828(417)

818 (633)

 Median

596

810

661

  1. HCC hepatocellular carcinoma, TCGA the cancer genome atlas, ICGC international cancer genome consortium